Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-02-26Clinical Trial Update: First-line Nab-paclitaxel Plus Cisplatin Plus Carilizumab in mTNBC Patients [Phase 2]
Phase 2 trial update on first-line nab-paclitaxel, cisplatin, and carilizumab in metastatic triple-negative breast cancer (mTNBC).
-
CLINICAL_TRIALS trial_result · 2024-02-23Clinical Trial Update: Combination Therapy With MYOCET® (Doxorubicin HCL Liposome for Injection) in Participants With HER2-Positive Breast Cancer [Phase 2]
Phase 2 trial update of MYOCET (doxorubicin liposome) in HER2-positive breast cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-02-23Clinical Trial Update: Evaluation of the Effect of Nigella Sativa for the Prophylaxis to Radiation Induced Dermatitis in Breast Cancer Patients [Phase 2]
Phase 2 clinical trial evaluating Nigella Sativa for prevention of radiation-induced dermatitis in breast cancer patients has completed.
-
CLINICAL_TRIALS trial_result · 2024-02-23Clinical Trial Update: Reducing Neutropenia Incidence With Pegfilgrastim Administration on Day 3 After Chemotherapy [Phase 4]
Phase 4 trial update evaluating pegfilgrastim given on day 3 after chemotherapy to reduce neutropenia in breast cancer patients.
-
CLINICAL_TRIALS trial_result · 2024-02-23Clinical Trial Update: Study of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy [Phase 1]
Phase 1 trial of F-627 in women with breast cancer receiving myelotoxic chemotherapy has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-02-22Clinical Trial Update: Accelerated Hypofractionated Radiotherapy (AHF-RT) for the Treatment of Breast Cancer [NA]
Clinical trial update on accelerated hypofractionated radiotherapy for breast cancer; study completed with results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: PROACT: Can we Prevent Chemotherapy-related Heart Damage in Patients With Breast Cancer and Lymphoma? [Phase 3]
Phase 3 trial update investigating PROACT to prevent chemotherapy-related heart damage in patients with breast cancer and non-Hodgkin lympho…
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: Pilot Decentralized Clinical Trial in Men and Pre and Post-menopausal Women With Breast Cancer and a Specific Mutation (PIK3CA) Treated With Alpelisib in Combination With Fulvestrant [Phase 2]
A Phase 2 decentralized trial in advanced breast cancer with a PIK3CA mutation evaluated alpelisib in combination with fulvestrant; the stud…
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: Patient Derived Organoid-guided Personalized Treatment Versus Treatment of Physician's Choice in Breast Cancer [Phase 3]
Phase 3 clinical trial evaluating patient-derived organoid-guided personalized treatment versus physician's choice in breast cancer is curre…
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: A Study of RC48-ADC Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer With or Without Liver Metastases [Phase 2, Phase 3]
A Phase 2/Phase 3 trial investigating RC48-ADC given IV in HER2-positive metastatic breast cancer, with or without liver metastases.
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: Adding Adjuvant Cisplatin and Gemicitabine Versus Capecitabine in Triple-negative Breast Cancer Patients in Non pCR After Neoadjuvant Standard Chemotherapy [Phase 2, Phase 3]
Clinical trial evaluating adjuvant cisplatin plus gemcitabine versus capecitabine in triple-negative breast cancer patients who did not achi…
-
CLINICAL_TRIALS trial_result · 2024-02-16Clinical Trial Update: Treatment Patterns and Clinical Outcomes Among Talazoparib-Treated Adults With HER2-Negative mBC With gBRCA1/2m
Clinical trial update evaluating talazoparib-treated adults with HER2-negative metastatic breast cancer and germline BRCA1/2 mutations, repo…
-
CLINICAL_TRIALS trial_result · 2024-02-16Clinical Trial Update: Niraparib Plus Aromatase Inhibitors for Luminal-like(HER2-,ER+) and gBRCA or HDR+ Metastatic Breast Cancer (LUZERN) [Phase 2]
Phase 2 clinical trial update evaluating niraparib in combination with aromatase inhibitors for luminal-like, HER2-negative, ER-positive met…
-
CLINICAL_TRIALS trial_result · 2024-02-16Clinical Trial Update: Oral Paclitaxel Efficacy Safety and PK in Recurrent and Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial assessing the efficacy, safety, and pharmacokinetics of oral paclitaxel in recurrent and metastatic breast cancer has…
-
CLINICAL_TRIALS trial_result · 2024-02-16Clinical Trial Update: Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients [Phase 2]
Phase 2 trial evaluating the repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in breast cancer patients, with the study status currently unk…
-
CLINICAL_TRIALS trial_result · 2024-02-15Clinical Trial Update: A Study of T-DXd for the Treatment of Solid Tumors Harboring HER2 Activating Mutations [Phase 2]
A Phase 2 clinical trial update shows results for trastuzumab deruxtecan (Enhertu) in solid tumors with HER2 activating mutations; the study…
-
CLINICAL_TRIALS trial_result · 2024-02-12Clinical Trial Update: Sunitinib in Treating Patients With Newly Diagnosed Stage II or Stage III Breast Cancer That Can Be Removed by Surgery [Phase 2]
Phase 2 clinical trial update evaluating sunitinib in newly diagnosed stage II/III breast cancer that can be removed by surgery.
-
CLINICAL_TRIALS trial_result · 2024-02-12Clinical Trial Update: Evaluate the Clinical Benefit of a Post-operative Treatment Associating Radiotherapy + Nivolumab + Ipilimumab Versus Radiotherapy + Capecitabine for Triple Negative Breast Cancer Patients With Residual Disease [Phase 2]
Phase 2 trial evaluating radiotherapy with nivolumab and ipilimumab vs radiotherapy with capecitabine for residual disease in triple-negativ…
-
CLINICAL_TRIALS trial_result · 2024-02-12Clinical Trial Update: Study of Dotatate Imaging in Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating dotatate imaging in advanced breast cancer (Stage IV) is ongoing with status not specified.
-
CLINICAL_TRIALS trial_result · 2024-02-12Clinical Trial Update: Adaptive Training Exercise Programs for Improving Cardiorespiratory Fitness After Breast Cancer Treatment, The ACTIVATE Trial [NA]
A completed clinical trial evaluating adaptive training exercise programs to improve cardiorespiratory fitness after breast cancer treatment…
-
CLINICAL_TRIALS trial_result · 2024-02-09Clinical Trial Update: A Study of Pyrotinib Plus Capecitabine Combined With SRT in HER2+ MBC With Brain Metastases [Phase 2]
Phase 2 trial update evaluating pyrotinib plus capecitabine with stereotactic radiotherapy in HER2-positive metastatic breast cancer with br…
-
CLINICAL_TRIALS trial_result · 2024-02-08Clinical Trial Update: Efficacy and Safety of Fluzoparib Combined With Adjuvant Endocrine Therapy for HR+/HER2- SNF3-subtype Early Breast Cancer (BCTOP-L-A01) [Phase 3]
Phase 3 clinical trial evaluating fluzoparib plus adjuvant endocrine therapy for HR+/HER2- SNF3-subtype early breast cancer is currently rec…
-
CLINICAL_TRIALS trial_result · 2024-02-07Clinical Trial Update: Trastuzumab Deruxtecan (T-DXd) With Pyrotinib in First-line HER2-positive Unresectable or Metastatic Breast Cancer Trial [Phase 4]
Phase 4 trial update evaluating trastuzumab deruxtecan in combination with pyrotinib for first-line HER2-positive unresectable or metastatic…
-
CLINICAL_TRIALS trial_result · 2024-02-06Clinical Trial Update: Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast Cancer [Phase 2]
Phase 2 trial results for hypofractionated radiation therapy in Stage 0 to IIB breast cancer have been completed with results posted in 2024…
-
CLINICAL_TRIALS trial_result · 2024-02-06Clinical Trial Update: 4FMFES-PET Imaging of ER+ Advanced Breast Cancers [Phase 2]
Phase 2 clinical trial update evaluating 4FMFES-PET imaging in ER-positive advanced breast cancer.